Ascend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) ...

FDA Recall #D-0179-2021 — Class II — December 17, 2020

Recall #D-0179-2021 Date: December 17, 2020 Classification: Class II Status: Terminated

Product Description

Ascend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx Only Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-68

Reason for Recall

Failed Impurity/Degradation Specifications

Recalling Firm

Ascend Laboratories LLC — Parsippany, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

9,524 bottles

Distribution

Nationwide

Code Information

20141680, 20141681, 20141759

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated